These findings indicated that miR-23b-5p functioned as a tumor suppressor miRNA in the progression of liver cancer by decreasing the expression of FOXM1, and miR-23b-5p may serve as a novel diagnostic and prognostic biomarker for HCC. This evidence concerns the gene FOXM1 and neoplasm.